Datapoint: Centene Expands Relationship With Evolent
April 6
Centene Corp. and Evolent Health, a value-based clinical and administrative solutions provider, have expanded their partnership to bring improved oncology care to Centene’s Medicare Advantage members. The collaboration seeks to offer more personalized and coordinated oncology care for seniors, with the goal of improving health outcomes and quality of life for MA members. Centene and its WellCare subsidiary currently serve 1,279,623 MA members, making it the sixth-largest insurer in that market nationally. Centene in January completed its sale of Magellan Specialty Health to Evolent.
Source: AIS’s Directory of Health Plans
Meet Our Reporters
-
Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits
View Leslie Small's Profile -
Peter Johnson Reporter, Health Plan Weekly and Radar on Drug Benefits
View Peter Johnson's Profile -
Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jinghong Chen's Profile
